Patents by Inventor Kanneganti Murthy

Kanneganti Murthy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies against flagellin and uses thereof
    Patent number: 8263078
    Abstract: The present invention provides a novel class of monoclonal antibodies which have a high affinity, broad spectrum neutralizing reactivity to flagellin from various Gram-negative bacteria including, but not limited to, E. coli, Salmonella, Serratia, Proteus, Enterobacter, Citrobacter, Campylobacter and Pseudomonas. The present invention further provides methods of treating inflammatory bowel disease (IBD) and methods of treating enterobacterial infections using anti-flagellin antibodies in humans, other animals and birds.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: September 11, 2012
    Assignees: Inotek Pharmaceuticals Corporation, Yeda Research and Development Co., Ltd.
    Inventors: Nurit Rachamim, Andrew L. Salzman, Kanneganti Murthy
  • Antibodies against flagellin and uses thereof
    Patent number: 8173130
    Abstract: The present invention provides a novel class of monoclonal antibodies which have a high affinity, broad spectrum neutralizing reactivity to flagellin from various Gram-negative bacteria including, but not limited to, E. coli, Salmonella, Serratia, Proteus, Enterobacter, Citrobacter, Campylobacter and Pseudomonas. The present invention further provides methods of treating inflammatory bowel disease (IBD) and methods of treating enterobacterial infections using anti-flagellin antibodies in humans, other animals and birds.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: May 8, 2012
    Assignee: Inotek Pharmaceuticals Corporation
    Inventors: Andrew L. Salzman, Kanneganti Murthy
  • ANTIBODIES AGAINST FLAGELLIN AND USES THEREOF
    Publication number: 20100239583
    Abstract: The present invention provides a novel class of monoclonal antibodies which have a high affinity, broad spectrum neutralizing reactivity to flagellin from various Gram-negative bacteria including, but not limited to, E. coli, Salmonella, Serratia, Proteus, Enterobacter, Citrobacter, Campylobacter and Pseudomonas. The present invention further provides methods of treating infections and diseases using anti-flagellin antibodies in humans, other animals and birds.
    Type: Application
    Filed: March 4, 2010
    Publication date: September 23, 2010
    Applicant: INOTEK PHARMACEUTICALS CORPORATION
    Inventors: Kanneganti MURTHY, Andrew L. SALZMAN
  • Antibodies against flagellin and uses thereof
    Publication number: 20090208506
    Abstract: The present invention provides a novel class of monoclonal antibodies which have a high affinity, broad spectrum neutralizing reactivity to flagellin from various Gram-negative bacteria including, but not limited to, E. coli, Salmonella, Serratia, Proteus, Enterobacter, Citrobacter, Campylobacter and Pseudomonas. The present invention further provides methods of treating inflammatory bowel disease (IBD) and methods of treating enterobacterial infections using anti-flagellin antibodies in humans, other animals and birds.
    Type: Application
    Filed: September 5, 2008
    Publication date: August 20, 2009
    Applicants: Inotek Pharmaceuticals Corporation, Yeda Research and Development Co., Ltd.
    Inventors: Nurit Rachamim, Andrew L. Salzman, Kanneganti Murthy
  • Antibodies against flagellin and uses thereof
    Publication number: 20090191208
    Abstract: The present invention provides a novel class of monoclonal antibodies which have a high affinity, broad spectrum neutralizing reactivity to flagellin from various Gram-negative bacteria including, but not limited to, E. coli, Salmonella, Serratia, Proteus, Enterobacter, Citrobacter, Campylobacter and Pseudomonas. The present invention further provides methods of treating inflammatory bowel disease (IBD) and methods of treating enterobacterial infections using anti-flagellin antibodies in humans, other animals and birds.
    Type: Application
    Filed: September 5, 2008
    Publication date: July 30, 2009
    Applicant: Inotek Pharmaceuticals Corporation
    Inventors: Andrew L. Salzman, Kanneganti Murthy